###begin article-title 0
Control of IL-2Ralpha gene expression: structural changes within the proximal enhancer/core promoter during T-cell development
###end article-title 0
###begin p 1
To whom correspondence should be addressed. Tel: +33 491 758 404; Fax: +33 491 260 364; Email: imbert@marseille.inserm.fr
###end p 1
###begin p 2
###xml 651 652 624 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1133 1140 1102 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 493 498 <span type="species:ncbi:10090">mouse</span>
###xml 599 605 <span type="species:ncbi:10090">murine</span>
During T-cell development in thymus, CD25, the IL-2 receptor alpha chain (IL-2Ralpha) is already expressed in early double-negative (DN) thymocytes where commitment to T-cell lineage has been established, but subsequently IL-2Ralpha is dramatically down-regulated for the remainder of T-cell development. The loss of IL-2Ralpha expression after expression of the pre-TCR alpha:beta complex on the cell surface is essential for the later specific responses of mature T cells. Using appropriate mouse models and DMS genomic footprinting, we showed that the TATA box in the core promoter region of the murine IL-2Ralpha locus was occupied only in DN CD25+ T cells. Further, by chromatin immunoprecipitation assays, we evidenced that down-regulation of IL-2Ralpha transcription correlated with (i) loss of the basal transcriptional machinery; (ii) dissociation of histone acetylase p300 and BRG1, a member of the ATP-dependent chromatin remodeling complex SWI/SNF; and (iii) histone N-termini dephosphorylation plus deacetylation. In contrast, occupancy of the proximal enhancer region (positive regulatory region I) was not detected by in vivo genomic footprinting though constitutive accessibility of the promoter region for DNase I digestion both in the DN and double-positive stages correlated with the constitutive association of CBP and PCAF to the IL-2Ralpha core promoter. These results exemplify one mechanism by which a promoter enables transcription to switch on and off during T-cell differentiation.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c1">1</xref>
###xml 368 369 357 358 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c</sub>
###xml 378 379 367 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c2">2</xref>
###xml 396 397 378 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c</sub>
###xml 486 487 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c3">3</xref>
###xml 488 489 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c4">4</xref>
###xml 555 556 537 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c5">5</xref>
###xml 557 558 539 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c7">7</xref>
###xml 746 753 724 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 822 823 796 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c8">8</xref>
###xml 859 860 833 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c9">9</xref>
###xml 946 948 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c10">10</xref>
###xml 949 951 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c12">12</xref>
###xml 1072 1073 1042 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c9">9</xref>
###xml 812 820 <span type="species:ncbi:9606">patients</span>
###xml 832 836 <span type="species:ncbi:10090">mice</span>
###xml 998 1002 <span type="species:ncbi:10090">mice</span>
Interleukin 2 (IL-2) is the principal growth factor for antigen-activated T lymphocytes and it plays a pivotal role in peripheral tolerance through the elimination of self-reactive T cells by activation-induced cell death (1). IL-2 promotes T-cell proliferation by binding to a high affinity receptor composed of three transmembrane proteins, the alpha, beta and gammac chains (2). beta and gammac chains combine to form an intermediate-affinity receptor sufficient for IL-2 signaling (3,4) but cannot stimulate the proliferation of normal T lymphocytes (5-7). The main functions of the highly inducible alpha chain (CD25) are presumed to increase the affinity for IL-2, allowing responsiveness to the low levels of IL-2 physiologically produced in vivo. IL-2Ralpha is essential, as evidenced by autoimmunity in patients (8) and in mice lacking this protein (9). It was also suggested that the IL-2/IL-2R pathway is involved in thymic selection (10-12) though the phenotype of IL-2Ralpha-deficient mice seems to exclude a critical role for this component during ontogeny (9).
###end p 4
###begin p 5
###xml 230 231 230 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 234 235 234 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 297 298 297 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 301 302 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 354 355 354 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 362 363 362 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 581 582 581 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 586 587 586 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 606 607 606 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 611 612 611 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 632 633 632 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 637 638 637 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 662 663 662 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 667 668 667 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c13">13</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c15">15</xref>
###xml 912 914 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c16">16</xref>
###xml 915 917 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c19">19</xref>
###xml 1279 1281 1258 1260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c20">20</xref>
###xml 1553 1554 1528 1529 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1789 1791 1760 1762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c21">21</xref>
###xml 1792 1794 1763 1765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c27">27</xref>
###xml 1836 1838 1807 1809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c28">28</xref>
###xml 1839 1841 1810 1812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c29">29</xref>
###xml 1897 1899 1868 1870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c30">30</xref>
###xml 2443 2445 2398 2400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c31">31</xref>
###xml 699 703 <span type="species:ncbi:10090">mice</span>
###xml 792 796 <span type="species:ncbi:10090">mice</span>
###xml 1564 1569 <span type="species:ncbi:9606">human</span>
Developing thymocytes follow a strictly regulated differentiation program characterized through the expression of specific cell surface markers. The thymocyte precursors, which lack expression of both co-receptors CD4 and CD8 [CD4-CD8- double-negative (DN) cells], develop into an intermediate CD4+CD8+ double-positive (DP) stage before maturing into CD4+ or CD8+ single-positive (SP) cells and exiting the thymus. It is now well established that DN thymocytes represent an heterogeneous population that can be further subdivided into four consecutive developmental stages: DN CD44+CD25- (stage I), DN CD44+CD25+ (stage II), DN CD44-CD25+ (stage III) and DN CD44-CD25- (stage IV) (13-15). In mutant mice lacking the recombinase proteins RAG-1 or RAG-2, or in TCRbeta- or pre-Talpha-deficient mice, none of them form a pre-TCR complex, alpha/beta T-cell development is significantly arrested at the DN stage III (16-19). Therefore, productive TCRbeta chain rearrangement and assembly of the pre-TCR serves as the first checkpoint in T-lymphocyte development for stage III to stage IV transition. Signaling through pre-TCR mediates the transcriptional activation and repression of several genes, including IL-2Ralpha, and is critical for further proliferation and differentiation (20). After transition to the DP stage, thymocytes do not express IL-2Ralpha for the remainder of T-cell development. In resting mature lymphocytes its expression is physiologically triggered by antigen and co-stimulatory signals. In these cells, and more specifically in CD4+ T cells, human IL-2Ralpha is mainly regulated at the level of transcription by at least five positive regulatory regions (PRRI-PRRV) spread out over 12 kb. Each regulatory region appears to play a well defined and complementary role (21-27). For instance, PRRIII (-3786 to -3071) (28,29) and PRRV, located in the first exon (+3389 to +3596) (30), are two specific IL-2 responsive enhancers activated by inducible Stat5 proteins playing a crucial role in the IL-2/IL-2R autoregulatory loop which amplifies IL-2Ralpha transcription in the late stage of T-cell activation. Hence, IL-2Ralpha appears critically controlled by IL-2 contrary to the thymus where this cytokine is not directly involved in CD25/IL-2Ralpha transient expression during the transition from the DN stage to the DP stage. Thus, IL-2Ralpha appears to be independently regulated in primary and secondary lymphoid organs (31).
###end p 5
###begin p 6
###xml 378 385 370 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 512 514 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c32">32</xref>
###xml 623 624 611 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 635 637 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c17">17</xref>
###xml 638 640 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c18">18</xref>
###xml 641 643 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c33">33</xref>
###xml 676 677 664 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 725 727 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c34">34</xref>
###xml 755 757 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c35">35</xref>
###xml 776 783 761 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 946 954 927 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 972 979 953 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 436 442 <span type="species:ncbi:10090">murine</span>
###xml 500 505 <span type="species:ncbi:9606">human</span>
###xml 535 540 <span type="species:ncbi:10090">mouse</span>
###xml 570 574 <span type="species:ncbi:10090">mice</span>
In contrast to the wealth of information on transcriptional regulation of IL-2Ralpha in mature lymphocytes, no attempt has been previously made to identify the molecular mechanisms controlling its expression during ontogeny. In order to differentiate the molecular mechanism enabling IL-2Ralpha transcription to switch on and off in thymus and in the periphery, we investigated in vivo during T-cell development the organization of the murine IL-2Ralpha promoter which presents 78% identity with the human gene (32). Using appropriate mouse models such as RAG-deficient mice whose thymic development is arrested at the CD25+ DN stage (17,18,33) that can be rescued to the CD25- DP stage by expression of a TCRbeta transgene (34) or by anti-CD3 injection (35), we evidenced by in vivo footprinting that the occupation on TATA box (-33, -28) correlated with IL-2Ralpha gene expression in DN cells and with the binding of TATA binding protein (TBP) in vitro. As demonstrated in vivo by chromatin immunoprecipitation assay (ChIP), repression of the IL-2Ralpha gene in DP cells was associated with the disengagement of two components of the general transcription machinery, TBP and Pol II as well as two members of the chromatin modifying complexes, the histone acetyl transferase (HAT) coactivator p300 and the DNA-dependent ATPase BRG1. In contrast, the HAT coactivators CBP and PCAF remained specifically associated to the inactive IL-2Ralpha promoter in DP cells. We also observed that acetylation and/or phosphorylation of histone H3 and H4 bound to IL-2Ralpha promoter was reverted during DN to DP transition. The implications of these observations are discussed.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 8
###begin p 9
###xml 80 83 80 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c17">17</xref>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c18">18</xref>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c33">33</xref>
###xml 129 130 129 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 133 134 133 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 150 153 150 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 199 202 196 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 211 213 205 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Tg</sup>
###xml 216 218 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c34">34</xref>
###xml 237 240 231 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 352 355 340 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 361 363 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c35">35</xref>
###xml 425 426 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 4 8 <span type="species:ncbi:10090">mice</span>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">Mice</span>
The mice used in this study included wild-type C57BL/6J and RAG-1-deficient (Rag-/-) (17,18,33). To rescue the development of CD4+CD8+ thymocytes, Rag-/- mice expressing a TCRbeta transgene, P14 (Rag-/-, TCRbetaTg) (34) or 4-week-old Rag-/- mice injected intraperitoneally with anti-CD3epsilon monoclonal antibody (2C11; PharMingen, San Diego, CA) (Rag-/-CD3) (35) were alternatively used since they present an identical CD25- DN phenotype. Mice were maintained in a specific pathogen-free breeding facility and killed for analysis at between 4 and 6 weeks of age.
###end p 9
###begin title 10
DNase I hypersensitivity assay
###end title 10
###begin p 11
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c36">36</xref>
###xml 149 150 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8</sup>
###xml 220 221 220 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 232 233 232 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 404 405 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf291f1">1</xref>
###xml 495 498 491 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 642 643 634 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf291f1">1</xref>
###xml 589 594 <span type="species:ncbi:10090">mouse</span>
Isolation and DNase I digestion of nuclei and purification of genomic DNA were performed as described (36). Briefly, nuclei were isolated from 1 x 108 cells by lysis in 0.05% NP-40, suspended at a concentration of 2 x 107 and 5 x 107 nuclei per ml. Aliquots of nuclei were incubated for 3 min at room temperature. The amounts of DNase I (Amersham Life Science) used are indicated in the legend to Figure 1. DNA was purified by phenol-chloroform extraction and 15 microg of DNA was digested with EcoRI. Samples were resolved on a 1% agarose gel, and analyzed by Southern blot assay using a mouse IL-2Ralpha gene locus-specific probe (see Fig. 1A) which was amplified by PCR (primer mCD25-1, 5'-CCCAGGAAGATGCAGTAAAGGGGTTGACCC-3', and primer mCD25-2, 5'-CTTCCAAGACAGCAAAGCCAAACCATCCCTGG-3').
###end p 11
###begin title 12
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo</italic>
In vivo genomic footprinting assay
###end title 12
###begin p 13
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c22">22</xref>
###xml 105 113 105 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 118 125 118 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 166 169 166 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 174 177 174 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 185 187 182 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Tg</sup>
###xml 345 346 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 346 347 343 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 417 418 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 418 419 409 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 493 494 478 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 494 495 479 480 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
Genomic footprinting analyses were performed by the DMS/LM-PCR method as previously described (22) using in vitro and in vivo methylated genomic DNA purified from Rag-/-, Rag-/- TCRbetaTg and C57BL/6J wild-type thymocytes. The following oligonucleotide primers were used for the coding strand: primer 1, 5'-ATGGGATCAGGATGGAGGA-3' [(+136, +118), Tm 60degreesC]; primer 2, 5'-CTCTGCAGTATATTGGGTCAACCCC-3' [(+100, +76), Tm 63degreesC]; primer 3, 5'-GGGTCAACCCCTTTACTGCATCTTCCTGGG-3' [(+86, +57), Tm 68degreesC].
###end p 13
###begin title 14
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
In vitro DNase I footprinting assay
###end title 14
###begin p 15
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf291f2">2</xref>
###xml 243 244 239 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 408 409 400 401 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 554 555 522 523 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 730 735 <span type="species:ncbi:9606">human</span>
A radiolabeled 184-bp DNA probe was prepared by PCR amplification from WT genomic DNA using the primers shown in Figure 2B. The DNase I footprinting assays were performed in a final volume of 20 microl, with reaction mixtures containing 6 x 105 c.p.m. of the one-end radiolabeled fragments, 10 microl of 2x TBP binding buffer (20 mM Tris-HCl pH 7.5, 100 mM KCl, 100 mM NaCl, 0.2 mM EDTA, 4 mM DTT, 10 mM MgCl2, 8 mM spermidine, 35% glycerol, 200 microg/ml BSA), 0.5 microl of poly(dI.dC) (1 microg/microl), 0.25 microl of 1% NP-40, 2 microl of 25 mM CaCl2, and TG10EDK50 (10 mM Tris-HCl pH 7.5, 10% glycerol, 0.1 mM EDTA, 1 mM DTT, 50 mM KCl) to the final volume. The amount of protein used in different reactions was 1 microl of human TBP (500 ng/microl). The reaction mixtures were incubated at 25degreesC for 30 min. Digestion reactions were performed with 1 microl of DNase I (0.1 U/microl) for 60 s, and were stopped by 400 microl of stop solution (0.5% SDS, 50 mM sodium acetate, 50 microg of tRNA). Twice phenol-chloroform-extracted and ethanol-precipitated DNA pellets were resolved on an 8% denaturing polyacrylamide gel.
###end p 15
###begin title 16
ChIP assay
###end title 16
###begin p 17
###xml 18 21 18 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 26 29 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 893 895 865 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1453 1455 1419 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c37">37</xref>
###xml 1456 1458 1422 1424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c38">38</xref>
###xml 416 422 <span type="species:ncbi:9986">rabbit</span>
Chromatin from Rag-/-, Rag-/-TgP14 and B6 wild-type thymocytes was fixed and immunoprecipitated using the ChIP assay kit (Upstate Biotechnology) as recommended by the manufacturer. The purified chromatin was immunoprecipitated using 10 microg of anti-phosphorylated-H3 (p-H3), acetylated-H3 (Ac-H3) or acetylated-H4 (Ac-H4) (UBI), 10 microg of anti-TBP, Pol II, CBP, p300, BRG-1 or PCAF (Santa Cruz), or 5 microl of rabbit non-immune serum. The input fraction corresponded to 0.1 and 0.05% of the chromatin solution before immunoprecipitation. Following DNA purification, the presence of selected DNA sequences was assessed by PCR. Fourteen cycles were performed with the first primer set in 50 microl with 2 and 4% of immunoprecipitated material. Then, using 2 microl of the first PCR product, 25 additional cycles of PCR were performed with the mCD25-3'-2 primer set and 1 microCi of [alpha-32P]dCTP. PCR products were resolved in 8% acrylamide gels. A 2-fold dilution series was typically used for first PCR reaction. The primers used were as follows: mCD25-5', 5'-CACTTCCTATATGAGATCACAGAACAGAG-3'; mCD25-3'-1, 5'-CTCTGCAGTATATTGGGTCAACCCC-3' (first PCR, 198 bp product) or mCD25-3'-2, 5'-GGGTCAACCCCTTTACTGCATCTTCCTGGG-3' (second PCR, 184 bp product). For CD3epsilon, the primers were 5'-CCCCCACTCTCCTTCATCCT-3' and 5'-TGTTCCACCGCATCCTCTCA-3'. The PCR program and primer sequences used for Oct-2 and MyoD gene analysis were as previously described (37,38). The average size of the sonicated DNA fragments subjected to immunoprccipitation was 500 bp as controlled by ethidium bromide gel electrophoresis.
###end p 17
###begin title 18
RESULTS
###end title 18
###begin title 19
PRRI is constitutively accessible for DNase I digestion during ontogeny
###end title 19
###begin p 20
###xml 317 318 313 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 446 447 442 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 552 553 548 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 557 558 553 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 571 574 567 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 592 595 588 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 690 692 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c32">32</xref>
###xml 700 701 696 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf291f1">1</xref>
###xml 740 743 736 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 878 879 874 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf291f1">1</xref>
###xml 1023 1025 1019 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c39">39</xref>
###xml 1086 1089 1082 1085 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 1156 1159 1152 1155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 575 579 <span type="species:ncbi:10090">mice</span>
In order to determine whether loss of IL-2Ralpha expression during stage III to stage IV transition during thymocyte differentiation corresponds to changes in chromatin structure accessibility, DNase I hypersensitivity assays were performed using either wild-type thymocytes as a source of CD25 negative cells or CD25+ DN thymocytes of mice deficient for the recombination activating gene RAG-1. Indeed, wild-type thymocytes comprised mostly CD25- DP and SP cells (95% of thymus content) whereas thymocyte development is completely arrested at the CD44-CD25+ stage in Rag-/- mice. We used an EcoRI 5.2-kb segment extending from 4.6 kb 5' to 0.6 kb 3' of the major transcription start site (32) (Fig. 1A). Hybridization of Southern blots of EcoRI-digested genomic DNA with the 0.44-kb probe covering nucleotides (+56 to +496) revealed two DNase I hypersensitive (DH) sites (Fig. 1B). DH1 maps a region between the proximal enhancer PRRI and +1 and DH2 is located -1.35 kb, corresponding to two previously reported DH sites (39). Both sites appeared accessible to DNase I digestion in Rag-/- and WT T cells from thymus although the DH1 band was weaker in Rag-/- thymocytes suggesting that no major change in chromatin accessibility correlates with IL-2Ralpha down-modulation during T-cell development in thymus.
###end p 20
###begin title 21
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
Characterization of the core promoter element in the mouse IL-2Ralpha locus
###end title 21
###begin p 22
###xml 164 171 164 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 263 264 259 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 273 274 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 295 298 291 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 412 415 408 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 562 563 552 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 582 583 572 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 596 598 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c34">34</xref>
###xml 818 820 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c32">32</xref>
###xml 914 917 892 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 922 925 900 903 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 933 935 908 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Tg</sup>
###xml 960 961 935 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf291f2">2</xref>
###xml 1112 1113 1087 1088 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1120 1123 1095 1098 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 1310 1312 1281 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c40">40</xref>
###xml 1671 1673 1638 1640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c41">41</xref>
###xml 1821 1824 1788 1791 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 2048 2049 2015 2016 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2200 2202 2167 2169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c32">32</xref>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
###xml 605 610 <span type="species:ncbi:10090">mouse</span>
###xml 1124 1128 <span type="species:ncbi:10090">mice</span>
###xml 2178 2184 <span type="species:ncbi:10090">murine</span>
DNase I hypersensitivity assays can only reveal major changes in the chromatin structure at a given locus. In an attempt to characterize more subtle modifications, in vivo DMS footprintings were performed to analyze the promoter region of IL-2Ralpha locus in CD25+ and CD25- thymocytes using Rag-/- and WT mice, respectively. To determine the involvement of a functional pre-TCR, we also used thymocytes from Rag-/- mice expressing a TCRbeta transgene where the expression of TCRbeta chain restores the pre-TCR signaling and allows the differentiation of DN CD25+ cells into DP CD25- thymocytes (34). The mouse IL-2Ralpha promoter region, localized between nucleotides -400 and +20 relative to the major transcription initiation site, contains four TATA boxes, two GC boxes, two NF-kappaB and four AP-1 binding sites (32). No significant footprint was found on GC boxes, NF-kappaB and AP-1 binding sites in the Rag-/-, Rag-/- TCRbetaTg and WT thymocytes (Fig. 2A and data not shown). This absence of footprint was not apparently due to an heterogeneity of the thymocyte population analyzed since >95% are DN CD25+ in Rag-/- mice. We can also exclude a problem linked to DNA quality since the same batches were successfully used to characterize the occupancy of the TCRalpha enhancer during T-cell development (40). However, enhanced methylation of adenine bases was observed at different positions in comparison with naked DNA but without correlation with IL-2Ralpha expression status. Such enhanced adenine methylation in living cells has already been reported and is probably due to a difference in the buffer composition between naked DNA and nuclear extract samples (41). In contrast, an increased methylation on guanine -25 just downstream of TATA box (-33, -28) in the coding strand was reproducibly observed in Rag-/- thymocytes; however, this footprint was not observed in the non-coding strand (data not shown). This observation suggested the occupancy of TATA box (+33, -28) by TBP, its cognate DNA binding protein, was restricted to CD25+ DN thymocytes. Furthermore, no significant footprint (data not shown) was observed on identified regulatory elements within the murine PRRIII/IL-2rE (32) despite the presence of a strong constitutive DH site.
###end p 22
###begin title 23
Determination of the functional TATA box
###end title 23
###begin p 24
###xml 152 160 152 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 244 246 240 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 278 279 274 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf291f2">2</xref>
###xml 385 386 381 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf291f2">2</xref>
###xml 596 597 592 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 641 648 637 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 653 661 649 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 311 316 <span type="species:ncbi:9606">human</span>
###xml 740 745 <span type="species:ncbi:10090">mouse</span>
To lend further support for a specific binding of TBP to TATA box (-33, -28), we examined the binding efficiency of this TATA box to recombinant TBP by in vitro DNase I footprinting assay. An IL-2Ralpha promoter probe was prepared by PCR using 32P-labeled mCD25-3' primer (Fig. 2B). Highly purified recombinant human TBP efficiently bound to the TATA box (-33, -28) as shown in Figure 2C. In contrast, only weak protections were observed on TATA boxes (-92, -87) and (+2, +7). The most dramatic protection by TBP on TATA box (-33, -28) correlated with increased methylation of guanine -25 in CD25+ thymocytes. Collectively, the results from in vivo and in vitro footprintings are in agreement with TBP binding to TATA box (-33, -28) of the mouse IL-2Ralpha locus at the DN stage.
###end p 24
###begin title 25
###xml 68 75 64 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Recruitment of basal transcription machinery to IL-2Ralpha promoter in vivo
###end title 25
###begin p 26
###xml 304 305 300 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 325 328 321 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 341 342 337 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 717 724 703 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo</italic>
###xml 799 802 781 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 820 821 802 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf291f3">3</xref>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
Our observations suggested that TBP is recruited to the IL-2Ralpha promoter in DN but not DP thymocytes. To address this point, we carried out ChIP experiments that can establish whether a known transcription factor truly binds in the vicinity of a known regulatory element in living cells. Purified CD25+ thymocytes from Rag-/- mice or CD25- thymocytes from WT mice were treated with formaldehyde to cross-link protein-protein and protein-DNA complexes. Following precipitation by specific antibodies against Pol II and TBP, the IL-2Ralpha promoter fragment present in the immunoprecipitates was identified by PCR amplification. CD3epsilon and Oct-2 were used as active and inactive promoter controls, respectively. In vivo association of TBP and Pol II to IL-2Ralpha promoter was only found in Rag-/- thymocytes (Fig. 3). TBP and Pol II were permanently associated with the CD3epsilon promoter constitutively active at the DN and DP stages. In contrast, neither TBP nor Pol II fixation was found in the inactive Oct-2 promoter. Comparison of the recruitment of TBP and Pol II with the IL-2Ralpha promoter in the DN and DP stages evidenced that repression of IL-2Ralpha expression at the DP stage correlates with dissociation of TBP and RNA Pol II holoenzyme in DP thymocytes.
###end p 26
###begin title 27
###xml 129 136 125 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Recruitment of histone acetyl transferases and ATP-dependent chromatin-remodeling complex to the IL-2Ralpha core promoter region in vivo
###end title 27
###begin p 28
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c42">42</xref>
###xml 708 710 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c43">43</xref>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c44">44</xref>
###xml 1278 1280 1278 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c45">45</xref>
Besides the interactions of basal transcription machinery and site-specific activators, it has become widely accepted that modification of chromatin structure is an important regulatory mechanism. Nucleosome assembly appears to eliminate the ability of the general transcription factors such as TFIID and the RNA polymerase II holoenzyme to interact with promoter sequences. Thus, efficient transcription initiation by the basal transcription machinery requires the recruitment of components of the chromatin remodeling complexes (42). Chromatin modifying activities involve two general classes of protein complexes which differ in whether or not they use covalent modification to alter chromatin structure (43). The first class consists of the HATs and histone deacetylases which respectively modify covalently the N-terminal tails of nucleosomal histones (44). The mammalian GCN5/PCAF and the CBP/p300 proteins bear HAT activities and function as coactivators of transcription by the recruitment to promoters via their interaction with various DNA binding proteins. The second class consists of the ATP-dependent chromatin-remodeling complexes which facilitate the accessibility to DNA, altering chromatin structure by changing the location or conformation of the nucleosome (45). Among them, the multi-subunit complex SWI/SNF contains eight or more polypeptides in which the DNA-dependent ATPase is either the BRG1 or BRM1 protein.
###end p 28
###begin p 29
###xml 108 115 104 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 358 359 350 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 379 382 371 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 394 395 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf291f4">4</xref>
###xml 677 680 665 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 689 691 674 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Tg</sup>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
Since Pol II and TBP were bound to the IL-2Ralpha core promoter at the activated stage, we investigated the in vivo recruitment of CBP, p300 and GCN5/PCAF as well as of BRG1. Surprisingly, we found CBP and PCAF constitutively associated to the IL-2Ralpha promoter both in the activated and suppressive stages whereas p300 and BRG1 were only recruited in CD25+ thymocytes from Rag-/- mice (Fig. 4). The constitutive binding of CBP and PCAF correlated with the DNA accessibility to DNase I digestion both in the DN and DP stages whereas the dissociation of p300 and BRG1 correlated with the disengagement of the basal transcription machinery and IL-2Ralpha down-regulation in Rag-/-, TCRbetaTg mice.
###end p 29
###begin title 30
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
Histone acetylation and phosphorylation correlates with the transcriptional regulation of the mouse CD25/IL-2Ralpha promoter
###end title 30
###begin p 31
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c46">46</xref>
###xml 413 414 409 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf291f5">5</xref>
###xml 583 584 575 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 604 607 596 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 1113 1115 1099 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c37">37</xref>
###xml 1185 1186 1167 1168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1208 1209 1190 1191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 1297 1298 1276 1277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1307 1308 1286 1287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 621 625 <span type="species:ncbi:10090">mice</span>
N-terminal tail modifications of nucleosomal histones play a central role in transcription regulation allowing for dynamic changes in the accessibility of the underlying genome (46). According to the recruitment of CBP, PCAF and p300 to IL-2Ralpha promoter, the status of the histone proteins bound to this region was investigated by ChIP assay performed with anti-AcH3, anti-AcH4 and anti-pH3 antibodies. Figure 5A and C shows that H3 and H4 bound to IL-2Ralpha promoter were highly acetylated at DN stage. In contrast, H3 and H4 acetylation levels were dramatically reduced in CD25- thymocytes from Rag-/-, CD3-treated mice whereas both histones associated with the constitutively active CD3epsilon promoter were highly acetylated at both the DN and DP stages. As a negative control, H3 associated with the silent Oct-2 promoter was very weakly acetylated. Surprisingly, H4 bound to this inactive promoter was acetylated at both the DN and DP stages during T-cell development (data not shown). To exclude a lack of specificity of acetylated H4 binding, we used the inactive MyoD promoter as a negative control (37). H3 bound to the IL-2Ralpha promoter was also phosphorylated in CD25+ but much less in CD25- thymocytes. As expected, phosphorylated H3 bound to the active Dbeta-1 promoter in CD25+ and CD25- thymocytes (Spicuglia,S. and Ferrier,P., unpublished results). These observations evidenced that acetylation of H3 and H4, and phosphorylation of H3 associated with the IL-2Ralpha promoter region, were strongly reduced when the gene was repressed during the DN to DP transition. Hence, chromatin modification in the vicinity of the core promoter region corresponds to the expression pattern of the IL-2Ralpha gene during T-cell development in thymus.
###end p 31
###begin title 32
DISCUSSION
###end title 32
###begin p 33
###xml 275 278 267 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 318 319 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
In this study, we have investigated the identity of proteins associated with IL-2Ralpha promoter accessibility during T-cell development. Our studies have revealed that TATA box (-33, -28) in the IL-2Ralpha core promoter is specifically occupied in the DN thymocytes from Rag-/- mice. IL-2Ralpha expression at the CD25+ DN stage correlated with the specific recruitment of the basal transcription machinery components TBP and Pol II as well as the HAT coactivators CPB, p300 and PCAF, and the DNA-dependent ATPase BRG1, a component of the SWI/SNF chromatin remodeling complex. After undergoing selection for productive TCRbeta chain rearrangements and pre-TCR signaling, developing thymocytes proceed to the proliferation stage and dramatically down-regulate CD25/IL-2Ralpha expression very rapidly. Down-regulation of IL-2Ralpha transcription after pre-TCR signal correlates with (i) loss of the basal transcriptional machinery, (ii) disassociation of chromatin remodeling complexes and (iii) histone N-termini dephosphorylation and deacetylation on the core promoter region. However, the silenced IL-2Ralpha gene still maintains the accessibility to its proximal promoter/enhancer region. This accessibility correlates with constitutive binding of PCAF and CBP and may enable rapid re-activation of IL-2Ralpha in response to T-cell activation signals.
###end p 33
###begin p 34
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c46">46</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c47">47</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c48">48</xref>
###xml 1082 1084 1074 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c49">49</xref>
###xml 1663 1665 1647 1649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c50">50</xref>
###xml 1606 1611 <span type="species:ncbi:4932">yeast</span>
Modification of histone tails appears to act in concert as 'signaling platforms', providing a molecular code for the specific recruitment of transcription factors and coactivators to core promoter (reviewed in 46). For example, the acetylated histone N-termini interact with HAT and TAFII250 bromodomains (47,48) but also most probably with the bromodomain of BRG1/BRM proteins present in the SWI/SNF complex. BRG1 recruitment in DN thymocytes is in agreement with a role in chromatin remodeling for the SWI/SNF complex that allows association of TBP and Pol II holoenzyme, completion of PIC assembly at IL-2Ralpha core promoter and initiation of transcription. The engagement of CBP, p300 and PCAF, which possess intrinsic HAT activity, raises the question of functional redundancy. The dissociation of p300 after the DN to DP transition and the maintenance of CBP and PCAF suggest that each cofactor exerts a distinct and non-redundant role in IL-2Ralpha gene regulation. Several lines of evidence indeed point to functional differences between these three cofactors (reviewed in 49). p300 engagement correlated with the level of H3 and H4 acetylation and with TBP, Pol II and BRG1 recruitment to the active IL-2Ralpha promoter. In contrast, CBP and PCAF constitutive binding and the presence of a constitutive DH site appear to participate in the maintenance of a pre-assembled nucleo-protein complex at the IL-2Ralpha promoter in order to allow a rapid response to the incoming stimuli characteristic of mature T-cell activation. Accordingly, maintenance of activator proteins at specific promoters in yeast has already been reported despite their silencing (50).
###end p 34
###begin p 35
###xml 116 123 116 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 194 196 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c22">22</xref>
###xml 848 850 832 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c31">31</xref>
###xml 1016 1018 1000 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c51">51</xref>
###xml 1169 1171 1153 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c39">39</xref>
###xml 1758 1760 1714 1716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c22">22</xref>
###xml 1761 1763 1717 1719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c23">23</xref>
###xml 1764 1766 1720 1722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c52">52</xref>
###xml 1767 1769 1723 1725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c54">54</xref>
###xml 1915 1922 1867 1874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 172 177 <span type="species:ncbi:9606">human</span>
###xml 256 262 <span type="species:ncbi:10090">murine</span>
###xml 1513 1519 <span type="species:ncbi:10090">murine</span>
###xml 1841 1847 <span type="species:ncbi:10090">murine</span>
We have previously reported a correlation between pre-commitment to activation and detection of stable occupancy by in vivo footprinting within IL-2Ralpha PRRI enhancer in human mature T cells (22). Such T-cell-specific footprints were not observed in the murine DN, DP and WT thymocytes analyzed in the present study, suggesting that transcriptional activation of IL-2Ralpha in DN thymocytes and its down-modulation in DP thymocytes depend on different molecular mechanisms than those involved in mature peripheral blood T cells While further comparative analysis is required to identify the common and divergent peculiarities of Il-2Ralpha gene regulation in thymocytes and mature T cells, our results are in agreement with a previous report evidencing an independent regulation of IL-2Ralpha expression in primary and secondary lymphoid organs (31). Among the common features, the same TATA box seems to be used in thymocytes and peripheral T cells, whereas the promoter region contains four putative TATA boxes (51). The location of the two constitutive DH sites observed in thymocytes appear also identical to two previously reported DH sites in immature T cells (39). However, the distal site apparently corresponding to the so-called PRRIII/IL-2rE was apparently inducible upon IL-2 stimulation in mature T cells whereas IL-2Ralpha expression is independent of IL-2 during the early stage of ontogeny. Furthermore, we failed to detect any significant modification of the two NF-kappaB-binding sites within murine IL-2Ralpha/PRRI suggesting that transcriptional activation of the IL-2Ralpha gene at the DN stage in thymus may be NF-kappaB-independent while activation of NF-kappaB has been associated with IL-2Ralpha gene expression in mature T cells (22,23,52-54). Furthermore, none of the other identified regulatory elements within murine IL-2Ralpha/PRRI and PRRIII (data not shown) were found occupied by in vivo footprinting. However, HAT and SWI/SNF complexes lack sequence-specific DNA binding, and are therefore thought to be recruited to specific promoters via interactions with specific DNA binding proteins. The site-specific transcriptional activators required for IL-2Ralpha gene activation at the DN stage in thymus remain to be identified.
###end p 35
###begin p 36
###xml 262 264 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c55">55</xref>
###xml 265 267 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c56">56</xref>
###xml 601 603 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c20">20</xref>
###xml 821 824 796 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 831 833 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c57">57</xref>
###xml 1302 1304 1273 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c58">58</xref>
###xml 1322 1323 1289 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c9">9</xref>
###xml 825 829 <span type="species:ncbi:10090">mice</span>
###xml 1247 1251 <span type="species:ncbi:10090">mice</span>
###xml 1632 1638 <span type="species:ncbi:10090">murine</span>
Whereas both the mature TCR and the pre-TCR can trigger anti-apoptotic events and proliferative signals, the pre-TCR triggers several additional outcomes, including termination of TCRbeta locus rearrangements and induction of CD4 and CD8 expression (reviewed in 55,56). The pre-TCR-driven transition from the DN to DP compartment characterized by CD25 transient expression appears as a multi-branched program, involving distinct transduction pathways which can either activate gene expression such as TCRalpha, CD4 and CD8 or repress other genes such as RAG, germline Vbeta, preTalpha and IL-2Ralpha (20). In agreement with a direct role of pre-TCR signaling in its repression, IL-2Ralpha expression persisted to the DP stage in thymocytes expressing specifically beta-catenin in the absence of pre-TCR signaling in RAG-2-/- mice (57). Because of the crucial role of the IL-2/IL-2R system in the regulation of the magnitude and duration of T-cell immune response, inactivation of the IL-2Ralpha gene by pre-TCR signal in thymus is required to ensure the specificity of T-cell responses in the periphery. Indeed, most of the biologic effects of IL-2 are mediated through its high affinity receptor as evidenced by the almost identical phenotype of mice with targeted inactivation of the genes for IL-2 (58) and IL-2Ralpha (9). Beside its controversial role in thymocyte maturation, IL-2Ralpha provides a convenient model for the characterization of the molecular mechanisms involved in transcription repression by pre-TCR signaling. The absence of significant DMS footprinting on the known transcriptional regulatory elements within murine IL-2Ralpha PRRI suggests that transcription factors different from those involved in mature T lymphocytes ensure IL-2Ralpha activation and repression during thymocyte differentiation.
###end p 36
###begin p 37
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c59">59</xref>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c60">60</xref>
###xml 324 326 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c32">32</xref>
###xml 327 329 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c61">61</xref>
###xml 535 537 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c62">62</xref>
###xml 790 792 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c63">63</xref>
###xml 290 295 <span type="species:ncbi:9606">human</span>
###xml 300 305 <span type="species:ncbi:10090">mouse</span>
###xml 809 813 <span type="species:ncbi:10090">mice</span>
###xml 1040 1046 <span type="species:ncbi:10090">murine</span>
Gene-targeting studies have demonstrated the crucial role as a transcriptional repressor played by Ikaros in regulating multiple stages of B- and T-cell development (reviewed in 59,60). A putative target sequence has been identified overlapping the PRRI NF-kappaB binding site conserved in human and mouse IL-2Ralpha genes (32,61). However, we failed to observe any significant occupancy within this region and several lines of evidence seem to exclude a role for Ikaros in IL-2Ralpha repression during ontogeny and in mature T cells (62). Alternatively, activation or repression of genes may be regulated by activators or repressors which recognize the chromatin structure, such as SATB1 which appears to orchestrate the temporal and spatial expression of genes during T-cell development (63). In SATB1-null mice, IL-2Ralpha is ectopically transcribed in DP thymocytes strongly suggesting that SATB1 acts as a repressor during ontogeny. However, no functional SATB1-binding site has been identified so far in the regulatory regions of the murine IL-2Ralpha. Further work is required to clarify these issues.
###end p 37
###begin p 38
###xml 476 478 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf291c64">64</xref>
In summary, we evidenced for the first time that IL-2Ralpha repression during thymocyte differentiation is characterized by major reorganization of the transcription machinery and chromatin modifications associated with the IL-2Ralpha promoter in response to pre-TCR signaling. Furthermore, our studies provide another example that the particular order by which the chromatin-modifying activities are recruited and/or function to allow gene activation might be gene specific (64).
###end p 38
###begin title 39
Figures and Tables
###end title 39
###begin p 40
###xml 115 116 111 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 510 511 502 503 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 682 685 670 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 841 844 829 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
###xml 150 155 <span type="species:ncbi:10090">mouse</span>
###xml 553 558 <span type="species:ncbi:10090">mouse</span>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
###xml 608 613 <span type="species:ncbi:10090">mouse</span>
 Analysis of the promoter of the mouse IL-2Ralpha gene during T-cell development by DNase hypersensitivity assay. (A) Schematic representation of the mouse IL-2Ralpha gene promoter showing the location of DNase I hypersensitivity sites. The bracketed bar represents the probe. The broken arrow indicates the transcriptional start site (+1) and the open boxes represent, respectively, the location of the proximal regulatory region I and the IL-2 responsive enhancer. Arrows mark the positions of the DH sites (B) DNase I hypersensitivity pattern on the mouse IL-2Ralpha locus in the WT mice. Highly purified mouse thymocytes were prepared as described in Materials and Methods. The EcoRI-digested genomic DNA was analyzed by Southern blot using the locus-specific 0.44-kb probe. The amounts of DNase I used for WT were 8 and 16 U and for Rag-/-, 16 and 32 U.
###end p 40
###begin p 41
###xml 89 96 85 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 101 109 97 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 132 133 128 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 135 142 131 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo</italic>
###xml 257 265 249 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 269 276 261 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 314 317 306 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 322 325 314 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 333 335 322 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Tg</sup>
###xml 511 518 496 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 639 640 624 625 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 933 940 914 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 956 957 937 938 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 959 967 940 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
###xml 204 209 <span type="species:ncbi:10090">mouse</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 670 675 <span type="species:ncbi:10090">mouse</span>
###xml 1037 1042 <span type="species:ncbi:9606">human</span>
 Identification of the core promoter element, TATA box, in the mouse IL-2Ralpha locus by in vivo and in vitro footprinting assays. (A) In vivo footprinting analysis of the proximal promoter region of the mouse IL-2Ralpha gene. DMS/LM-PCR was performed with in vitro or in vivo methylated DNA from thymocytes of Rag-/-, Rag-/- TCRbetaTg and WT mice. Localization of the putative regulatory elements within the proximal regulatory region of the IL-2Ralpha gene is indicated on the right side. The arrow marks the in vivo footprinting and the circular marks the enhanced methylation of adenine bases in living cells compared with naked DNA. (B) Partial DNA sequence of the mouse IL-2Ralpha promoter region. The radiolabeled 184-bp DNA fragment was prepared by PCR amplification with the primers mCD25-5' and mCD25-3'. Open frames show the positions of three putative TATA boxes. The arrow indicates the guanine residue -25 evidenced by in vivo footprinting. (C) In vitro DNase I footprinting was performed using highly purified recombinant human TBP (hTBP) as indicated above the panel. The G+A sequence ladder is shown on the right lane and the position of the three TATA on the left side.
###end p 41
###begin p 42
###xml 84 91 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 150 153 146 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 202 207 <span type="species:ncbi:10090">mouse</span>
###xml 388 394 <span type="species:ncbi:9986">rabbit</span>
 Recruitment of basal transcription factors, Pol II and TBP, to IL-2Ralpha promoter in vivo. PCR analysis of chromatin-immunoprecipitated DNA from Rag-/- and WT thymocytes with specific primers for the mouse IL-2Ralpha core promoter. The input fraction corresponded to 0.1 and 0.05% of the chromatin solution before immunoprecipitation. DNA-protein complexes were immunoprecipitated with rabbit non-immune serum (n.i.) or specific Pol II, TBP antibodies. CD3epsilon and Oct-2 promoter regions were also analyzed as positive and negative controls, respectively.
###end p 42
###begin p 43
###xml 113 120 109 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 140 143 136 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 151 154 147 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 214 219 <span type="species:ncbi:10090">mouse</span>
###xml 335 341 <span type="species:ncbi:9986">rabbit</span>
 Recruitment of HATs CBP, p300 and GCN5/PCAF, and the chromatin-remodeling complex, BRG1, to IL-2Ralpha promoter in vivo. Chromatin from Rag-/- and Rag-/-TgP14 thymocytes was analyzed by specific PCR assay for the mouse IL-2Ralpha/PRRI. The input fraction is the same as in Figure 4. DNA-protein complexes were immunoprecipitated with rabbit non-immune serum (n.i.) or specific CBP, p300, PCAF or BRG1 antibodies. The ChIP assay controls included the CD3epsilon and Oct-2 promoter regions.
###end p 43
###begin p 44
###xml 93 94 89 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 153 156 149 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 165 168 161 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 462 463 445 446 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 468 469 451 452 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 191 196 <span type="species:ncbi:10090">mouse</span>
###xml 269 275 <span type="species:ncbi:9986">rabbit</span>
 Modifications of the histone proteins correlate with the expression pattern of IL-2Ralpha. (A) PCR analysis of chromatin-immunoprecipitated DNA from Rag-/-, and Rag-/-CD3 thymocytes for the mouse IL-2Ralpha promoter. DNA-protein complexes were immunoprecipitated with rabbit non-immune serum (n.i.) or specific Ac-H3, Ac-H4 or p-H3 antibodies. CD3epsilon and Dbeta-1 were the activ gene controls and Oct-2 and MyoD promoter regions the inactive gene controls. (B and C) Densitometric quantification relative to the input fraction of the level of histone acetylation and of H3 phosphorylation, respectively.
###end p 44
###begin title 45
ACKNOWLEDGEMENTS
###end title 45
###begin p 46
We thank Jean-Marc Egly for his invaluable help in the purification of the recombinant protein hTBP, Dominique Payet and Terumi Kowhi-Shigematsu for helpful discussion, and Brigitte Kahn-Perles for critical reading of the manuscript. This work was supported by institutional grants from INSERM and CNRS, and by a specific grant from Association pour la Recherche sur le Cancer Recherche Medicale. J.-H.Y. was supported by a fellowship from French government (BGF).
###end p 46
###begin title 47
REFERENCES
###end title 47

